Implantium India Profile
Key Indicators
- Authorised Capital ₹ 37.00 Cr
as on 04-12-2024
- Paid Up Capital ₹ 30.90 Cr
as on 04-12-2024
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.90 Cr
as on 04-12-2024
- Revenue 0.44%
(FY 2024)
- Profit 6.25%
(FY 2024)
- Ebitda -2.77%
(FY 2024)
- Net Worth -53.63%
(FY 2024)
- Total Assets -10.62%
(FY 2024)
About Implantium India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 37.00 Cr and a paid-up capital of Rs 30.90 Cr.
The company has closed loans amounting to ₹4.90 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Implantium India Private Limited India is Richa Kaushik as COMPANY SECRETARY. Lokesh Kumar, Juhwan Yun, Deepak Kumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999HR2015FTC057492
- Company No.
057492
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
08 Dec 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Implantium India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Richa Kaushik | Company Secretary | 20-Sep-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lokesh Kumar  | Director | 21-Jun-2021 | Current |
| Juhwan Yun | Director | 26-Dec-2022 | Current |
| Deepak Kumar | Director | 26-Dec-2022 | Current |
| Yongki Kwon | Director | 24-Feb-2023 | Current |
Financial Performance of Implantium India.
Implantium India Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 0.44% increase. The company also saw a slight improvement in profitability, with a 6.25% increase in profit. The company's net worth observed a substantial decline by a decrease of 53.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Implantium India?
In 2023, Implantium India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 05 Sep 2018 | ₹4.90 Cr | Satisfied |
How Many Employees Work at Implantium India?
Implantium India has a workforce of 99 employees as of Dec 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Implantium India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Implantium India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
